Motus GI Holdings, Inc. (MOTS)
Motus GI Holdings, Inc. operates as a medical technology company in the United States.
It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures.
The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016.
Motus GI Holdings, Inc. was founded in 2008 and is based in Fort Lauderdale, Florida.
|IPO Date||Feb 14, 2018|
1301 East Broward Boulevard, 3rd Floor
Ft. Lauderdale, Florida 33301
|Fiscal Year||January - December|
|Timothy P. Moran||Chief Executive Officer and Director|
|Mark Pomeranz||President, Chief Operating Officer and Director|
|Andrew Lawrence Taylor M.B.A.||Chief Financial Officer|
|Scott C. Aldrich Jr.||Vice President of Global Marketing and Strategy|
Latest SEC Filings
|Nov 27, 2023||8-K||Current Report|
|Nov 13, 2023||10-Q||Quarterly Report|
|Nov 13, 2023||8-K||Current Report|
|Nov 2, 2023||8-K||Current Report|
|Oct 20, 2023||S-1||General form for registration of securities under the Securities Act of 1933|
|Oct 2, 2023||8-K||Current Report|
|Sep 22, 2023||SC 13G||Statement of acquisition of beneficial ownership by individuals|
|Sep 21, 2023||8-K||Current Report|
|Sep 14, 2023||8-K||Current Report|
|Sep 7, 2023||DEFA14A||Additional definitive proxy soliciting materials and Rule 14(a)(12) material|